Daniel P Steinfort1, Shankar Siva, Tomas Kron, Raphael R Chee, Jeremy D Ruben, David L Ball, Louis B Irving. 1. *Department of Medicine, University of Melbourne, Parkville, Australia; †Department of Respiratory Medicine, Royal Melbourne Hospital, Parkville, Australia; ‡Department Cancer Medicine, Peter MacCallum Cancer Institute, East Melbourne, Australia; §Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Institute, East Melbourne, Australia; ║Department of Physical Sciences, Peter MacCallum Cancer Institute, East Melbourne, Australia; ¶Radiation Oncology, Genesis Cancer Care WA, Perth, Australia; #School of Surgery, University of Western Australia, Perth, Australia; **William Buckland Radiotherapy Centre, Prahran, Australia; and ††Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
Abstract
INTRODUCTION: Fiducial markers act as visible surrogates of tumor position during image-guided radiotherapy. Marker placement has been attempted percutaneously but is associated with high rates of pneumothorax and chest drain placement. METHODS: Patients undergoing radical radiation treatment for non-small-cell lung cancer underwent bronchoscopic implantation of gold fiducials using radial probe endobronchial ultrasound (EBUS) with virtual bronchoscopy and fluoroscopic guidance to achieve tumor localization and placement within/adjacent to peripheral lung tumors. For tumors not localized using radial EBUS, fiducial placement was achieved by electromagnetic navigation to the vicinity of the tumor. RESULTS: Eighteen fiducials were placed to mark 16 lesions in 15 patients. In nine patients (60%), fiducials were implanted at the time of diagnostic bronchoscopy. No procedural complications occurred. EBUS localization allowed marker implantation within the target lesion in 12 cases. In four lesions, electromagnetic navigation bronchoscopy-guided implantation achieved a median fiducial-lesion distance of 6 mm (mean 12 mm). No marker migration occurred after the implantation of two-band markers; however, early migration was observed in two of eight (25%) of the smaller linear fiducials. No migration during the course of radiation therapy was observed. CONCLUSION: Fiducial marker placement is easily and safely performed bronchoscopically, including at the time of diagnostic bronchoscopy. Marker geometry appears important in stability of bronchoscopically inserted fiducials. Future studies are required to confirm the optimal marker size, geometry, and spatial relationship with the target lesion.
INTRODUCTION: Fiducial markers act as visible surrogates of tumor position during image-guided radiotherapy. Marker placement has been attempted percutaneously but is associated with high rates of pneumothorax and chest drain placement. METHODS:Patients undergoing radical radiation treatment for non-small-cell lung cancer underwent bronchoscopic implantation of gold fiducials using radial probe endobronchial ultrasound (EBUS) with virtual bronchoscopy and fluoroscopic guidance to achieve tumor localization and placement within/adjacent to peripheral lung tumors. For tumors not localized using radial EBUS, fiducial placement was achieved by electromagnetic navigation to the vicinity of the tumor. RESULTS: Eighteen fiducials were placed to mark 16 lesions in 15 patients. In nine patients (60%), fiducials were implanted at the time of diagnostic bronchoscopy. No procedural complications occurred. EBUS localization allowed marker implantation within the target lesion in 12 cases. In four lesions, electromagnetic navigation bronchoscopy-guided implantation achieved a median fiducial-lesion distance of 6 mm (mean 12 mm). No marker migration occurred after the implantation of two-band markers; however, early migration was observed in two of eight (25%) of the smaller linear fiducials. No migration during the course of radiation therapy was observed. CONCLUSION: Fiducial marker placement is easily and safely performed bronchoscopically, including at the time of diagnostic bronchoscopy. Marker geometry appears important in stability of bronchoscopically inserted fiducials. Future studies are required to confirm the optimal marker size, geometry, and spatial relationship with the target lesion.
Authors: Kashif Ali Khan; Pietro Nardelli; Alex Jaeger; Conor O'Shea; Padraig Cantillon-Murphy; Marcus P Kennedy Journal: Adv Ther Date: 2016-03-22 Impact factor: 3.845
Authors: Ki Man Ku; Bing Lam; Vincent W C Wu; Kwok Ting Chan; Chloe Y Y Chan; H C Cheng; Kamy M Y Yuen; Jing Cai Journal: Front Oncol Date: 2022-06-16 Impact factor: 5.738
Authors: Steen Riisgaard de Blanck; Jonas Scherman Rydhög; Klaus Richter Larsen; Paul Frost Clementsen; Mirjana Josipovic; Marianne Camille Aznar; Per Munck Af Rosenschöld; Rasmus Irming Jølck; Lena Specht; Thomas Lars Andresen; Gitte Fredberg Persson Journal: Clin Transl Radiat Oncol Date: 2018-08-02